Checkpoint inhibitors in ovarian cancer: A review of preclinical data

Ovarian cancer is the deadliest gynecologic malignancy, and relapse after initial treatment is frequently fatal. Although ovarian cancer typically has an immunosuppressive tumor microenvironment, a strong intratumoral T cell presence is associated with an improved response to chemotherapy and better...

Descripción completa

Detalles Bibliográficos
Autores principales: Doo, David W., Norian, Lyse A., Arend, Rebecca C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Narrative Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609798/
https://www.ncbi.nlm.nih.gov/pubmed/31312712
http://dx.doi.org/10.1016/j.gore.2019.06.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609798/
https://www.ncbi.nlm.nih.gov/pubmed/31312712
http://dx.doi.org/10.1016/j.gore.2019.06.003

Ejemplares similares